Novartis Aktie
128,14
EUR
-0,16
EUR
-0,12
%
128,16
EUR
-0,82
EUR
-0,64
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.10.16 | Novartis Hold | S&P Capital IQ | |
| 24.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.10.16 | Novartis Outperform | Bernstein Research | |
| 19.10.16 | Novartis Underweight | Morgan Stanley | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 13.10.16 | Novartis buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 10.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.09.16 | Novartis Neutral | BNP PARIBAS | |
| 13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.08.16 | Novartis buy | Kepler Cheuvreux | |
| 04.08.16 | Novartis buy | Jefferies & Company Inc. | |
| 04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis Outperform | Bernstein Research | |
| 20.07.16 | Novartis Neutral | UBS AG | |
| 20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.16 | Novartis Halten | Independent Research GmbH | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.07.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 12.07.16 | Novartis Underweight | Morgan Stanley | |
| 07.07.16 | Novartis buy | Kepler Cheuvreux | |
| 06.07.16 | Novartis Halten | Independent Research GmbH | |
| 23.06.16 | Novartis Hold | Deutsche Bank AG | |
| 31.05.16 | Novartis Underweight | Morgan Stanley | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis Neutral | Citigroup Corp. | |
| 19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.05.16 | Novartis Underweight | Morgan Stanley | |
| 18.05.16 | Novartis Neutral | Citigroup Corp. | |
| 11.05.16 | Novartis buy | Jefferies & Company Inc. | |
| 09.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 28.04.16 | Novartis Neutral | UBS AG | |
| 26.04.16 | Novartis Outperform | Bernstein Research | |
| 26.04.16 | Novartis buy | HSBC | |
| 26.04.16 | Novartis Neutral | BNP PARIBAS | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novartis Underweight | Morgan Stanley | |
| 22.04.16 | Novartis Equal weight | Barclays Capital | |
| 21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.04.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 15.04.16 | Novartis Neutral | UBS AG | |
Werbung
Werbung